85
Participants
Start Date
April 30, 2015
Primary Completion Date
July 31, 2016
Study Completion Date
August 31, 2016
Intravenous infusions of Xyntha
Enrolled subjects will be treated with intravenous infusions of Xyntha for: • On-Demand treatment, • Surgical Prophylaxis at a dose and frequency prescribed by the subject's treating physician in accordance with the Xyntha label and will be adjusted solely according to medical and therapeutic necessity.
Beijing Children's hospital, Beijing
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine/Hematology Department, Shanghai
Department of Hematology/Children's Hospital of Shanghai, Shanghai
Department of Hematology,The First Affiliated Hospital of Soochow University, Suzhou
Blood Center of Shandong Province, Jinan
Blood Diseases Hospital, Chinese Academy of Medical Science (Institute of Hematology), Tianjin
Department of Hematology,Jiangxi Provincial People's Hospital, Nanchang
The second affiliated hospital of chongqing medical university, Chongqing
Children's Hospital of Chongqing Medical University, Chongqing
Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan
Henan Provincial People's Hospital, Zhengzhou
Hematology Department, Nanfang Hospital, Southern Medical University, Guangzhou
The Affiliated Hospital of Guizhou Medical University, Guiyang
Chengdu Women's and Children's Central Hospital, Chengdu
Department of Hematology,The First Affiliated Hospital of Kunming Medical University, Kunming
Lead Sponsor
Pfizer
INDUSTRY